Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$79,812,468
in 11 filings, $79.8M under 10b5-1 plans

Net −$79,812,468. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-01-31 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Employee stock option (right to buy) +54,500 54,500
2023-01-31 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Performance-based restricted stock units +6,750 6,750
2023-01-31 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +20,250 62,626
2023-01-31 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Employee stock option (right to buy) +54,500 54,500
2023-01-31 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Performance-based restricted stock units +6,750 6,750
2023-01-31 Heerma Peter Chief Commercial Officer Grant or award +20,250 83,848
2023-01-31 Heerma Peter Chief Commercial Officer Grant or award · Employee stock option (right to buy) +54,500 54,500
2023-01-31 Heerma Peter Chief Commercial Officer Grant or award · Performance-based restricted stock units +6,750 6,750
2023-01-31 Cline Christopher R. Chief Financial Officer Grant or award +20,250 53,121
2023-01-31 Cline Christopher R. Chief Financial Officer Grant or award · Employee stock option (right to buy) +54,500 54,500
2023-01-31 Cline Christopher R. Chief Financial Officer Grant or award · Performance-based restricted stock units +6,750 6,750
2023-01-31 Inrig Jula Chief Medical Officer Grant or award +20,250 37,757
2023-01-31 Inrig Jula Chief Medical Officer Grant or award · Employee stock option (right to buy) +54,500 54,500
2023-01-31 Inrig Jula Chief Medical Officer Grant or award · Performance-based restricted stock units +6,750 6,750
2023-01-31 Dube Eric M Chief Executive Officer Grant or award +97,500 245,346
2023-01-31 Dube Eric M Chief Executive Officer Grant or award · Employee stock option (right to buy) +260,000 260,000
2023-01-31 Dube Eric M Chief Executive Officer Grant or award · Performance-based restricted stock units +32,500 32,500
2023-01-31 Calvin Sandra SVP, Chief Accounting Officer Grant or award +10,000 44,836
2023-01-31 Calvin Sandra SVP, Chief Accounting Officer Grant or award · Employee stock option (right to buy) +20,000 20,000
2023-01-25 Calvin Sandra SVP, Chief Accounting Officer Sale −192 $21.63 $4K 34,836

Page 28 of 51 · 1,020 trades